Close

Syros Pharmaceuticals (SYRS) Presents Data from Phase 1/1b Clinical Trial of SY-5609

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Syros Pharmaceuticals (SYRS) Presents Data from Phase 1/1b Clinical Trial of SY-5609
(NASDAQ: SYRS) Delayed: 5.10 +0.03 (0.59%)
Previous Close $5.07    52 Week High $21.50 
Open $4.94    52 Week Low $8.16 
Day High $5.15    P/E N/A 
Day Low $4.92    EPS $0.00 
Volume 128,576